The Suppression of Medulloblastoma Cell Migration Using Clinically Significant Doses of Simvastatin through Mevalonate Pathway Targeting
<b>Aims:</b> Medulloblastoma (MBs), the most prevalent malignant paediatric brain tumour, exhibits distinct subgroups—Wingless (WNT), Sonic Hedgehog (SHH), Group 3 (G3), and Group 4 (G4)—and each is characterized by unique molecular signatures and clinical outcomes [...]
Tallennettuna:
| Päätekijät: | , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
MDPI AG
2024-03-01
|
| Sarja: | Proceedings |
| Aiheet: | |
| Linkit: | https://www.mdpi.com/2504-3900/100/1/6 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|